Confirmed Virologic Failure at or Prior to Week 48 At or prior to Week 48 [clinicaltrials_resource:e8b66e9393901979ff6a465d7e0434a2]
Confirmed virologic failure was defined as two successive HIV-1 RNA measurements at least 24 hours apart that were either:1) <1 log10 copies/mL below the baseline level and >400 copies/mL at the week 12 HIV-1 RNA evaluation (obtained at least 11 weeks after the date of the randomization) 2) >400 copies/mL at or after the week 24 HIV-1 RNA evaluation (obtained at least 23 weeks after the date of randomization). 3) subjects who discontinued the study follow-up for any reason other than study completion, including death, and who did so ≤50 weeks after randomization was considered to be a virologic failure. Number of participants experiencing or not experiencing virologic failure at or prior to week 48 was reported.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Confirmed Virologic Failure at or Prior to Week 48 At or prior to Week 48 [clinicaltrials_resource:e8b66e9393901979ff6a465d7e0434a2]
Confirmed virologic failure was defined as two successive HIV-1 RNA measurements at least 24 hours apart that were either:1) <1 log10 copies/mL below the baseline level and >400 copies/mL at the week 12 HIV-1 RNA evaluation (obtained at least 11 weeks after the date of the randomization) 2) >400 copies/mL at or after the week 24 HIV-1 RNA evaluation (obtained at least 23 weeks after the date of randomization). 3) subjects who discontinued the study follow-up for any reason other than study completion, including death, and who did so ≤50 weeks after randomization was considered to be a virologic failure. Number of participants experiencing or not experiencing virologic failure at or prior to week 48 was reported.
Bio2RDF identifier
e8b66e9393901979ff6a465d7e0434a2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e8b66e9393901979ff6a465d7e0434a2
measure [clinicaltrials_vocabulary:measure]
Confirmed Virologic Failure at or Prior to Week 48
time frame [clinicaltrials_vocabulary:time-frame]
At or prior to Week 48
description
Confirmed virologic failure wa ...... prior to week 48 was reported.
identifier
clinicaltrials_resource:e8b66e9393901979ff6a465d7e0434a2
title
Confirmed Virologic Failure at or Prior to Week 48 At or prior to Week 48
@en
type
label
Confirmed Virologic Failure at ...... 66e9393901979ff6a465d7e0434a2]
@en